Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Wen Shi Lee & Olga Amengual. (2020) B cells targeting therapy in the management of systemic lupus erythematosus. Immunological Medicine 43:1, pages 16-35.
Read now
Read now
Robert J. Benschop, Chi-Kin Chow, Yu Tian, James Nelson, Barbra Barmettler, Shane Atwell, David Clawson, Qing Chai, Bryan Jones, Jon Fitchett, Stacy Torgerson, Yan Ji, Holly Bina, Ningjie Hu, Mahmoud Ghanem, Joseph Manetta, Victor J. Wroblewski, Jirong Lu & Barrett W. Allan. (2019) Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs 11:6, pages 1175-1190.
Read now
Read now
William Stohl. (2017) Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE). Expert Review of Clinical Immunology 13:6, pages 623-633.
Read now
Read now
Bharath Wootla, Jens O. Watzlawik, Nikolaos Stavropoulos, Nathan J. Wittenberg, Harika Dasari, Murtada A. Abdelrahim, John R. Henley, Sang-Hyun Oh, Arthur E. Warrington & Moses Rodriguez. (2016) Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opinion on Biological Therapy 16:6, pages 827-839.
Read now
Read now
Valeria Magarotto, Marco Salvini, Francesca Bonello, Sara Bringhen & Antonio Palumbo. (2016) Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins. Leukemia & Lymphoma 57:3, pages 537-556.
Read now
Read now
Wendy J. Komocsar, Jamie L. Blackbourne, Carolyn A. Halstead, Colleen J. Winstead & Daniel Wierda. (2016) Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations. Journal of Immunotoxicology 13:1, pages 7-19.
Read now
Read now
Emanuele D’Amico, Cinzia Caserta & Francesco Patti. (2015) Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives. Expert Review of Neurotherapeutics 15:3, pages 251-268.
Read now
Read now
Articles from other publishers (4)
YuXue Nie, Lidan Zhao & Xuan Zhang. (2021) B Cell Aberrance in Lupus: the Ringleader and the Solution. Clinical Reviews in Allergy & Immunology 62:2, pages 301-323.
Crossref
Crossref
Bingyi Yang, Ming Zhao, Haijing Wu & Qianjin Lu. (2020) A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target. Frontiers in Immunology 11.
Crossref
Crossref
Ken-Hong Lim, Caleb Gon-Shen Chen, Yu-Cheng Chang, Yi-Hao Chiang, Chen-Wei Kao, Wei-Ting Wang, Chiao-Yi Chang, Ling Huang, Ching-Sung Lin, Chun-Chia Cheng, Hung-I Cheng, Nai-Wen Su, Johnson Lin, Yi-Fang Chang, Ming-Chih Chang, Ruey-Kuen Hsieh, Huan-Chau Lin & Yuan-Yeh Kuo. (2017)
Increased B cell activation is present in
JAK2
V617F-mutated,
CALR
-mutated and triple-negative essential thrombocythemia
. Oncotarget 8:20, pages 32476-32491.
Crossref
Crossref
Clifton O. BinghamIIIIII, Kevin L. Winthrop, Lili Yang, Chin Lee & Wendy J. Komocsar. (2015) BAFF inhibition does not significantly impair immunization responses in patients with rheumatoid arthritis. Arthritis Research & Therapy 17:1.
Crossref
Crossref